Extended Donor Criteria Have No Negative Impact on Early Outcome After Liver Transplantation: A Single-Center Multivariate Analysis

Abstract The organ shortage has driven many transplant centers to accept extended donor criteria and to modify graft allocation policies. This study was designed to analyze the impact of applying extended donor criteria (EDC) in orthotopic liver transplantation (OLT). Between December 2001 and Decem...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2007-03, Vol.39 (2), p.529-534
Main Authors: Schemmer, P, Nickkholgh, A, Hinz, U, Gerling, T, Mehrabi, A, Sauer, P, Encke, J, Friess, H, Weitz, J, Büchler, M.W, Schmidt, J
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Biological and medical sciences
Child
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Liver Function Tests
Liver Transplantation - mortality
Liver Transplantation - physiology
Male
Medical sciences
Middle Aged
Multivariate Analysis
Patient Selection
Retrospective Studies
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Survival Analysis
Tissue Donors - supply & distribution
Tissue, organ and graft immunology
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The organ shortage has driven many transplant centers to accept extended donor criteria and to modify graft allocation policies. This study was designed to analyze the impact of applying extended donor criteria (EDC) in orthotopic liver transplantation (OLT). Between December 2001 and December 2004, we performed 165 primary cadaveric whole OLTs. Up to three EDC, that is, ventilation >7 days; aminotransferases (ALT or AST) >3× normal; bilirubin >3 mg/dL; anti-HBc or HBs Ag positivity; donor age >65 years; liver steatosis >40%; donor body mass index >30; cold ischemia time >14 hours; peak serum Na+ >165 mmol/L; history of extrahepatic malignancy; or previous drug abuse were present in 55% of all grafts. Both univariate and multivariate analysis revealed that EDC status had no effect on graft or patient survival, the necessity for retransplantation, the length of intensive care/intermediate care unit stay, mechanical ventilation, complications, or posttransplant laboratory findings. Recipient age of ≥55 years was the only independent prognostic factor for survival, regardless of EDC. These findings suggested that the use of grafts from EDC donors are safe and expand the donor pool.
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2006.12.002